Status:

COMPLETED

Processing Speed as an Objective Measure of Tinnitus

Lead Sponsor:

Washington University School of Medicine

Collaborating Sponsors:

Posit Science Corporation

Conditions:

Tinnitus

Eligibility:

All Genders

18-80 years

Brief Summary

The overall purpose of this research is to assess whether both the "60 second Brain Game" and the "Brain Speed Test" computer-based programs can be used as assessment tools for objectively defining th...

Detailed Description

This cross-sectional study aims to assess for deficits in brain processing speed and attention (two cognitive domains whose deficits have been implicated in tinnitus) with the use of the "Brain Speed ...

Eligibility Criteria

Inclusion

  • Participants must be between the ages of 18 and 80.
  • Participants must have subjective, unilateral or bilateral, non-pulsatile tinnitus of 6-months duration or longer.
  • Participants must be able to read, write and speak using the English language.
  • Participants must be able to provide informed consent.

Exclusion

  • Participants with tinnitus related to Workman's Compensation Claim or other litigation-related situations.
  • Participants with active diagnoses of any acute or chronic brain-related neurological conditions that alter normal brain anatomy or function including Parkinson's disease, Multiple Sclerosis, Alzheimer's Disease, cerebral infarcts, traumatic brain injury, history of brain tumor(s), epilepsy, or dementia.
  • Participants with tinnitus related to retrocochlear lesions, cochlear implants, or other known anatomic/structural lesions of the brain, skull-base, temporal bone or ear.
  • Participants unable to hear the highest volume of the computer-based objective assessments.
  • Any medications that may affect or alter cognition including but not limited to sedatives, hypnotics, narcotics, or opiates.
  • Any medical condition the PI determines would compromise the safety of the participant or complicate the interpretation of the study results.

Key Trial Info

Start Date :

July 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2010

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT01222507

Start Date

July 1 2010

End Date

October 1 2010

Last Update

October 25 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110